Abstract-The aim of this paper is to provide an alternative and more efficient screening test for allergy with respect to traditional UNICAP and prick skin tests, which are commercially available nowadays. The proposed test is aimed at monitoring the interaction of the IgE protein with the allergen in an allergic subject. The idea relies on the fact that the interaction between the IgE and the corresponding allergen happens through binding mechanisms between the IgE and the allergen structure, changing the ionic content of the serum. This latter can be monitored by impedance measurements and confirmed by reactive oxygen species (ROS) evaluation in leukocyte subpopulations. Therefore, in this paper we propose a novel system for the detection of allergies based on impedance measurements and confirmed by ROS measurements. This type of measurement approach has never been presented in the literature for this purpose. A measurement protocol has been developed to guarantee reproducibility and repeatability of the assay. This paper describes both the instrument-specifically designed for impedance evaluationand the measurement protocols for both methodologies, defining univocally, in this way, the overall measurement technique.
Detection of Allergen-IgE interaction in Allergic
Children Through Combined Impedance and ROS Measurements I. INTRODUCTION
I
MMUNOGLOBULINS are heterodimeric proteins composed of two heavy and two light chains. They can be separated functionally into variable domains that bind antigens and constant domains that specify effector functions, such as activation of complement or binding to Fc receptors. Each variable domain can be split into three regions of sequence variability, termed the complementarity-determining regions and four regions of relatively constant sequence, named the framework regions.
The binding between antigen and the variable domain of the antibody is weak and essentially noncovalent. Electrostatic interactions, hydrogen bonds, van der Waals forces, and hydrophobic interactions are all known to be involved depending on the interaction sites [1] , [2] . There are five main classes of heavy chain constant domains. Each class defines the IgM, IgG, IgA, IgD, and IgE isotypes.
Although it is present at the lowest serum concentration and has the shortest half-life, IgE is a very reactive immunoglobulin. It is associated with hypersensitivity and allergic reactions, as well as with the response to parasitic worm infections. IgE binds with extremely high affinity to FcεRI, which is expressed on mast cells, basophils, Langerhans cells, and eosinophils. Circulating IgE upregulates FcεR expression on these cells. The combination of strong binding and upregulation of FcεR expression contributes to the remarkable potency of this immunoglobulin.
IgE was initially identified in 1967 as the reagent that mediates type I hypersensitivity [3] , [4] in 1972, the first commercial assay for allergen-specific IgE had been developed [5] called the RAST. The original RAST was configured as a paper disk allergosorbent on which many different allergens of varying specificities were covalently coupled. Serum was incubated with this solid-phase allergen, permitting antibodies of all isotypes to bind. After a buffer wash to remove unbound proteins, bound IgE antibody was detected with radioiodinated polyclonal antihuman IgE. After this second incubation and a second buffer wash, bound radioactivity was quantified in a gamma counter. The entire test required three days. The number of counts per minute was proportional to the amount of IgE antibody specifically bound to the immobilized allergen.
In recent years, improvement of technology in the solid-phase component has led to the development of the ImmunoCAP system (Pharmacia Diagnostics) for in vitro testing. This test uses a 3-D cellulose solid phase instead of the 2-D paper disks of the modified RAST. As a result, incubation times can be decreased. These newer IgE antibody assays use a larger number and higher quality of allergen extracts for preparing their allergosorbents. New matrix materials such as the cellulose sponge used in the Pharmacia CAP system have enhanced the binding capacity while reducing the nonspecific binding properties of allergosorbents. Various polyclonal and monoclonal anti-IgE detection antibody combinations ensure maximal assay sensitivity and specificity for human IgE. Nonisotopic labels have increased the shelf life of reagents and have made the assays more user friendly and safer to perform. Automation has improved assay precision and reproducibility 0018-9456 © 2017 IEEE. Personal use is permitted, but republication/redistribution requires IEEE permission.
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to the level where some IgE antibody assays on autoanalyzers require only singlicate measurements to ensure accurate results. Calibration systems used in the second-generation IgE antibody assays have employed a common strategy in which a (heterologous) total serum IgE curve is used to convert allergen-specific IgE assay response data into quantitative dose estimates of IgE antibody. The entire assay time is about 6 h. Besides the above described tests, two other diagnostic laboratory assays for determination of specific serum IgE have been developed. The Immulite system from Siemens (Berlin, Germany) uses a biotinylated allergen that is bound to an avidin solid phase. The HYTEC-288 system from Hycor/Agilent Technologies (Santa Clara, CA) uses a cellulose wafer on which allergen is covalently coupled. All these tests are performed on autoanalyzers to maximize precision and minimize the turnaround time. They all use nonisotypically labeled antihuman IgE and are calibrated by means of interpolation of response data from a heterologous total serum IgE calibration curve that has been referenced to the World Health Organization total IgE serum standard [6] .
These serologic assays have evolved from dichotomous qualitative measures of IgE antibody (e.g., positive versus negative) to a more quantitative status. In fact, clinical research has shown that, in certain cases, the level of allergen-specific IgE antibody can be predictive of a positive allergen challenge test such as the one related to food allergy and the presence of more severe disease (e.g., wheeze) in children with asthma [7] , [8] . However, serum IgE concentrations do not accurately predict the severity of allergic reaction, but do reflect the likelihood of an allergic reaction of variable intensity.
To gather information about the actual allergic reaction severity reactive oxygen species (ROS) in several blood cell lines can be measured. In fact, there is recent evidence for ROS being involved in both the initial and later stages of allergic inflammation: FcεRI cross-linking results in intracellular ROS production within mast cells. However, the role of oxidants in signaling events leading to degranulation, eicosanoid synthesis, and cytokine secretion is still to be conclusively determined. Interestingly, treatment with natural antiallergic agents reduced the elevation of intracellular ROS production caused by FcεRI activation [9] .
In this context, we propose a new test for allergy detection, based on the monitoring of the serum impedance during and after its interaction with a given allergen. The impedance measurement is performed at a fixed frequency during the allergenIgE reaction and once reached the steady state a spectroscopic analysis is performed in a large frequency range. To obtain these measurements a dedicated instrument was developed, which is a portable and low cost impedance analyzer, equipped with a dedicated fluid sampling system designed to work on little and well-controlled quantities of serum and allergens and to obtain a repeatable and controllable system under test.
Impedance measurements are widely used in several medical applications, ranging from noninvasive diagnosis [10, 11] to body impedance analysis for the fat-free mass content [12] and fluid balance or in biosensors for the detection of a huge variety of different biotargets. Nevertheless, they have never been applied to allergy detection, according to the authors' knowledge.
The proposed approach improves the performance of the current test for serum IgE concentration in terms of assay time and, furthermore, provides information about the IgE binding kinetics that is related to the severity of the allergic reactions. The test effectiveness is confirmed by ROS production measurement in leukocyte subpopulations.
II. MEASUREMENT PRINCIPLE AND DEVICE

A. Impedance Measurements: Instrument and Protocol
The idea at the basis of the proposed measurement technique relies on the fact that traditional UNICAP and prick tests cannot discriminate/predict mild or severe allergic reactions in every patient providing both the quantitative and dynamic information on IgE-allergen interaction. Such interaction between the IgE and the corresponding allergen happens through an electrochemical bonding mechanism, which changes the serum impedance in a measurable way according to the number of IgE that bond to the allergen. A meaningful information on the severity of allergic response may be linked to the bonding speed. The proposed measurement instrument is therefore an impedance measurement device [13] - [18] built by means of a proper hardware structure, a software, and an interdigitated (or simple noble metal pad stripes) baseplate to host the organic samples to be tested. The analysis is performed on serum [material under test (MUT)] obtained by spinning and properly filtering from blood or alternatively obtained in a separate spinning phase. Such medium still contains several substances that can provide weird responses if biased with constant voltage in the case of DC resistance measurements. Therefore, the choice of operating in the AC regime from 1 up to 100 kHz with a resolution of at least 100 Hz, is due to the need of minimizing the interaction and biasing of the MUT during the measurement phases and to preserve its properties as far as possible. Tests have been conducted with several drops with quantity ranging from some μL up to tens of μL of serum. The preliminary results reported in this paper refer to experiments conducted with 50 μL volume drops and at the specific frequency of 30 kHz even if the system can work with a minimum quantity of 25 μL. Nevertheless, this small amount will complicate greatly the fluid sampling system affecting measurements' repeatability and reliability. It was found that with the selected volume, the absolute value of the MUT impedance is typically in the range from hundreds of to tens of k . The schematic of the developed impedance measurement system is described in Fig. 1 , it can be seen that the instrument comprises an integrated circuit (AD5933), which performs the impedance measurement, a fluid sampling system, which delivers the MUT across the measuring electrodes, and finally a control unit, a touch screen, and a memory card. The system can operate as a stand-alone instrument or it can be interfaced with a PC by an Ethernet link. The system is flexible; it allows to perform impedance measurements at a fixed frequency and impedance spectroscopy, and to set during the tests the frequency step and range, the measurement time and the Fig. 1 . Schematic of the proposed device. Setup messages are generated from the ARM controller for the impedance meter (using I2C bus). Measurement results are returned by the impedance meter IC to the ARM processor on the same bus. The arm microcontroller also controls the sampling system containing the MUT. As already stated, the core of the impedance measurement is the integrated circuit AD5933, a programmable Impedance Converter Network Analyzer (1 MSPS, 12 bit). The measurement parameters, such as frequency and AC signal amplitude, can be set using a I2C bus by a dedicated software. The chip provides the measurement outputs in terms of real and imaginary parts of the impedance at the selected frequency using the same I2C. The AD5933 is interfaced to the control unit (ARM controller), which controls the measurement process and acquires measurement data.
The sampling system (shown in detail in Fig. 2 ) consists of a reaction chamber (disposable eppendorf) in which both the allergen and the serum are delivered by two peristaltic pumps. These latter are controlled by the control unit. Two level sensors provide the signals for the measurement start and stop. Two noble metal needles (measurement electrodes), inserted in the reaction chamber are the "measurement electrodes" across which the impedance of the MUT is measured.
Normally, the measurement process consists of performing an impedance measurement at a fixed frequency (30 kHz) of each 128 ms, starting when the serum and the allergen come into contact until the steady state is reached and then performing a frequency scan (in the range 1-100 kHz), providing the impedance spectrum of the MUT at the end of the serumallergen reaction. The steady state is automatically detected by the measurement system when the impedance value at the present measurement time differs by less than 1% from the average of 10 previously acquired values.
All the impedance measurement of MUTs reported in this paper are performed after the compensation for the droplet support impedance.
Moreover, to select the optimum measurement parameters (such as AC signal amplitude) the following preliminary procedure is followed. For each different patient, at first a drop (50 μL) of serum is characterized in order to build a subject impedance baseline.
After this preliminary step, the eppendorf is changed and a fixed volume of the medium holding the allergen quantity is pumped across the sensing electrodes. Once the measured impedance has reached a steady state, the additional drop of the subject serum of the same volume is added and the actual measurement starts (dynamic at fixed frequency followed by impedance spectroscopy in chemical steady state).
The obtained measurements are an indication of the protein interaction with the allergen: the speed of the impedance change can be used to determine the reaction rate and the dynamics of the allergen-protein interaction.
The proposed measurement system exploits an intuition that the authors have investigated for a long time on a gas sensing system where ionized semiconductors' surface resistance measurements are taken to detect the interaction with reducing or oxidant gases [19] , [20] .
In addition, for result validation ROS measurement has been performed to assess the IgE-allergen interaction. The method for ROS measurement is hereby described.
B. ROS Production by Fluorescence-Activated Cell Sorting Analysis
After collection, 100 μl EDTA-anticoagulated blood samples have been resuspended in 2 mL of BD FACS lysing solution (Becton Dickinson Biosciences, San Jose, CA, USA), gently mixed, and incubated at RT in the dark for 10 min. Next, cells have been centrifuged, the supernatant discarded, and the cells washed twice in PBS. To determine the level of intracellular ROS generation, cells have been incubated with H 2 DCF-DA (2.5 μM) (Invitrogen, CA, USA) in RPMI without serum and phenol red for 15 min at 37°C. After labeling, cells have been washed and resuspended in PBS and analyzed immediately using a FACSCanto flow cytometer (Becton-Dickinson, San Jose, CA). The sample flow rate has been adjusted to about 1000 cells/s. For a single analysis, the fluorescence properties of 20 000 leukocytes have been collected. The respective gates have been defined using the distinctive forward-scatter and side-scatter properties of the individual cell populations. Moreover, cell viability has been controlled by flow cytometry with propidium iodide staining [21] , [22] . BD FACSDiva software (BectonDickinson, San Jose, CA, USA) has been used for data analysis.
C. Overall Measurement Procedure
To better understand the measurement results reported in this paper a measurement flow diagram is reported for clarity in Fig. 3 .
The overall measurement is divided into five separate phases. During Phase I, blood samples are collected in BD Vacutainer venous blood collection tubes for serum separation and in EDTA-anticoagulated BD tubes (0.17 mol/L) for the two parallel measurements (impedance measurements and ROS detection respectively). In Phase II, after centrifugation (1500 xg for 15 min at 4°C), serum aliquots are stored for further processing. At the same time, EDTA-anticoagulated blood samples are processed as described above. Briefly, after red blood cell lysis, leukocyte subpopulations are incubated with H 2 DCF-DA fluorescence probe for ROS detection and analyzed by FACS.
Phase III corresponds to the dynamic IgE-allergen interaction, during which impedance measurements at fixed frequency (typically 30 kHz) are performed. Typically, this phase lasts around 2 min and allows the collection of information about the reaction kinetics, such as the response time or time constants and the final steady-state value. These parameters may allow to formulate, in the future, a suitable interaction model as it has been supposed in [18] - [20] . In Phase IV, two parallel measurements take place. On one side, an impedance spectroscopy is taken over with a frequency span of 99 kHz and a starting frequency of 1 kHz. ROS detection is performed in leukocyte subpopulations (lymphocytes, monocytes, and granulocytes) according to the specific already reported protocol [22] , [23] .
Finally, during Phase V the results are collected and the outcomes are compared for verification.
III. PRELIMINARY EXPERIMENTAL RESULTS
A. Measurement System Validation
In order to test the proposed measurement system some measurements were performed using reference impedances. In particular, circuits as those shown in Figs. 4 and 6 were selected since their topology models the behavior of the electrodes/ionic liquid system we deal with.
The tested circuit as per Fig. 4 has R1=R2=470 while the capacitance C1=100 nF.
In Fig. 5 the spectroscopy analysis, comparing the theoretical behavior of the previously mentioned circuit (crosses) with the measured values (circles) in the frequency range (10-100kHz) show good agreement within the system accuracy expectations.
The circuit in Fig. 6 with R1=R2=R3=330 and C1=100 nF and C2=10 nF was tested and characterized over frequency as well.
In Figs. 7-9 the comparison between the theoretical and measured values of both the absolute value and phase are represented. Instrument accuracy (magnitude) is within 2% of the measured value across the frequency range of interest.
B. Measurement With Serum Samples
Some blood serum samples have been tested to identify the response of allergic subjects to a specific allergen, i.e., the cow milk (casein). In the following, the response obtained with Fig. 7 . Impedance absolute value for circuit in Fig. 6 (crosses ideal) (circles measurements). Fig. 8 .
Impedance phase for circuit in Fig. 6 (crosses ideal) (circles measurements). two allergens (casein and parsley) for two different children are reported. Parsley is chosen as the reference "negative" substance due to the fact that the allergy to this allergen is really uncommon in children. The results of the proposed measurement depend on the concentration of the allergen to be investigated (allergen dependent): the optimal concentration of 100 mg/mL of allergen for cow milk was used.
Figs. 10 and 11 show the dynamic behavior over time of the MUT impedance absolute value during IgE-allergen interaction for a patient allergic to casein (and not to parsley) and one nonallergic, respectively.
It can be noticed from the data in Fig. 10 that when an allergic reaction is present the impedance over time plot has a peculiar behavior. At first, the absolute value of impedance decreases quickly and then it increases reaching a large steadystate value (not reached in the time interval shown in Fig. 10 ).
In Fig. 12 , some preliminary and promising results are reported based on the possibility to discriminate four cow's milk allergic children with three different UNICAP results (100, between 40 and 100, and less than 2 KU/L, respectively). These results suggest that the magnitude of the impedance gives a direct indication of the allergy severity. Fig. 13 shows the impedance spectroscopy corresponding to the interaction of an allergic child serum with milk (UNICAP >100 KU/L) and Parsley (UNICAP 0 KU/L), respectively. Such responses show how the impedances resulting from the interaction of milk with specific IgE have larger values in all the tested frequency range. In the figure, data from two repeated experiments are reported. Fig. 12 . Preliminary results showing the steady-state impedance module in allergic subjects at four different cow's milk serum IgE levels (three subjects with 2, 50 and 100 KU/L), measurements are performed at frequency = 30 kHz. Fig. 13 . Impedance spectroscopy of a dairy allergic child with respect to casein and parsley, respectively, evaluated in the range 1-90 kHz.
Fig. 14. Impedance spectroscopy of a nonallergic child with respect to casein and parsley, respectively, evaluated in the range 10-90 kHz. Fig. 15 . Impedance spectroscopy of a child allergic to cow milk (not to parsley) (A) and a negative subject (B) with respect to casein and parsley, respectively, evaluated in the range 10-90 kHz. Fig. 14 shows the same experiment on the serum of a negative child. Repeated measurements almost overlap and prove the system measurement repeatability.
Finally, Fig. 15 points out that it is possible even to discriminate the degree of allergies.
Finally, Fig. 16 shows the good correspondence between the detection results and clinical information. Actually the treated Fig. 16 .
Impedance spectroscopy of a subject allergic to both casein (35KU/L) and tree nuts (20KU/L) and no-allergy to parsley. Good agreement with the clinical behavior of the subject once in contact with the allergen is confirmed by the measurement results. Fig. 17 . Lymphocyte/monocyte/granulocyte ROS production in nonallergic and allergic children. Group mean ± SD of 15 patients and 20 controls, calculated by considering the overall mean of different experiments/replicates as single value for each subject are reported. subject, presents a 35 KU/L UNICAP result for casein and almost 20 KU/L for tree nuts. Upon direct giving of casein and tree nuts only the first one can be clinically reported for the subject as an allergic reaction while the second kind of food has just negligible consequences on the patient as could be also predictable by the impedance behavior in Fig. 16 .
C. ROS Production by FACS Analysis
ROS generation has been assessed on different leukocyte subpopulations. We suggest peripheral leukocytes as a new and reliable model for studying oxidative stress-mediated homeostasis alterations. Furthermore, circulating leukocytes are readily accessible and retain their original phenotype offering important advantages for cellular and molecular studies [20] . For all these reasons, in the present study, we used leukocytes, which represent a "time-persistent" system capable of reflecting the condition of the whole organism.
In the literature, plasma oxidative stress markers have been shown to be increased in allergic subjects but no data are present on ROS production by leukocytes in the same subjects. Our results clearly show an increased ROS production in all the three leukocyte subpopulations (lymphocytes, monocytes, granulocytes) in allergic subjects compared to controls (Fig. 17) . In particular, the effect size indexes based on the difference between means are 2.3830, 2.5001, and 2.5074 for the three populations respectively. Data reported in this figure concerns 15 patients and 20 controls. Considering the central role of ROS in the allergic reactions, our results can explain, at least in part, the different impedance profile observed in allergic and nonallergic children.
IV. CONCLUSION
In this paper, the authors have presented a new tool for monitoring the specific IgE-allergen interaction in allergic children by means of serum impedance measurement and ROS production assessment. A portable and low cost instrument for impedance measurement has been developed, and characterized in the working range with known impedances.
A measurement procedure has been defined and preliminary measurements give promising results showing that an overall oxidative stress is present in the blood of allergic subjects. Further studies are needed to better understand the possible relationships between the investigated parameters.
As an advantage with respect to traditional tests in the new proposed method for determination of serum IgE, no antihuman IgE is needed, and only allergen and serum have to be used. This technique is simpler compared to RAST/Immunocap because it minimizes the possible loss of allergenic epitopes in the preparation of the solid phase, and it is more rapid and cheaper (only the allergen cost) than the immunoenzymatic one.
At the moment, this procedure has been applied to a patient sample size of 15 patients and it has been able to discriminate always between allergic and nonallergic children in accordance with traditional tests.
